Quick Answer
Zepp Health Corp reported R&D Expense of $46.16 million for fiscal year 2024.
Zepp Health Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $46.16M | -10.4% |
| 2023 | $51.50M | -33.4% |
| 2022 | $77.30M | -85.0% |
| 2021 | $515.08M | -4.3% |
| 2020 | $538.01M | +24.9% |
| 2019 | $430.82M | +63.7% |
| 2018 | $263.22M | +71.1% |
| 2017 | $153.83M | +16.3% |
| 2016 | $132.30M | +114.9% |
| 2015 | $61.55M | — |
- Zepp Health Corp showed a decrease of -10.4% in R&D Expense compared to the prior fiscal year.
- Over the 2015–2024 period, Zepp Health Corp’s r&d expense has declined by 25.0% (from $61.55 million to $46.16 million).
- The most recent figure is from Zepp Health Corp’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: